Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Andrew J. Tatar"'
Autor:
Amanda Contreras, Megan V. Beems, Andrew J. Tatar, Siddhartha Sen, Prakrithi Srinand, M. Suresh, Tahra K. Luther, Clifford S. Cho
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-10 (2018)
Abstract Background Adoptive cell transfer (ACT) is a promising cancer immunotherapeutic strategy that remains ineffective for a large subset of patients. ACT with memory CD8+ T cells (Tmem) has been shown to have superior efficacy compared to tradit
Externí odkaz:
https://doaj.org/article/eb2887f0b5f44212a684a09fbb01f14c
Autor:
Megan V. Beems, Prakrithi Srinand, Siddhartha Sen, Clifford S. Cho, Andrew J. Tatar, M. Suresh, Tahra Luther, Amanda Contreras
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-10 (2018)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
Background Adoptive cell transfer (ACT) is a promising cancer immunotherapeutic strategy that remains ineffective for a large subset of patients. ACT with memory CD8+ T cells (Tmem) has been shown to have superior efficacy compared to traditional ACT
Autor:
Prakrithi Srinand, M. Suresh, Siddhartha Sen, Andrew J. Tatar, Clifford S. Cho, Amanda Contreras, David A. Mahvi, Justin V. Meyers
Publikováno v:
Cancer immunology, immunotherapy : CII. 65(5)
Adoptive cell transfer (ACT) melanoma immunotherapy typically employs acutely activated effector CD8+ T cells for their ability to rapidly recognize and clear antigen. We have previously observed that effector CD8+ T cells are highly susceptible to m
Autor:
Glen Leverson, David A. Mahvi, Clifford S. Cho, M. Suresh, Andrew J. Tatar, Siddhartha Sen, Amanda Contreras, Justin V. Meyers
Immunotherapeutic approaches to the treatment of advanced melanoma have relied on strategies that augment the responsiveness of endogenous tumor-specific T cell populations (e.g., CTLA-4 blockade-mediated checkpoint inhibition) or introduce exogenous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be989d3d960e846d6776e6d8e46661eb
https://europepmc.org/articles/PMC4321765/
https://europepmc.org/articles/PMC4321765/
Autor:
Clifford S. Cho, Justin V. Meyers, Prakrithi Srinand, Amanda Contreras, Siddhartha Sen, David M. Mahvi, Andrew J. Tatar
Publikováno v:
Journal for Immunotherapy of Cancer
Our laboratory has previously demonstrated that adoptive cell transfer (ACT) of melanoma-specific memory T cells (TM) results in a more potent local and systemic T cell response than ACT with melanoma-specific effector T cells (TE). However, we have